On the morning of August 7, the mother-daughter duo of Hema, 51, and Chhavi Damani, 26, decided to twin in their T-shirts, trousers and masks. A short prayer followed, before they headed for the Zydus Hospital in Ahmedabad for a “noble cause”—volunteer for the phase 2 trials of ZyCoV-D, one of the possible Covid vaccines developed by pharmaceutical major Zydus Cadila.
“My husband is a physician at the hospital,” says Hema, a homemaker. “One day, he came home and informed us that Zydus Cadila is going to start the second round of human trials. My daughter and I asked him if we could be a part of it.” Both didn’t have any second thoughts in putting their hands up as they knew that getting volunteers would be key to running successful trials.
A day before getting the jab, Hema and Chhavi went to the hospital for a screening, a blood profile and RT-PCR tests to ensure they didn’t have any antibodies already. Trial participants are expected to have normal blood pressure and sugar levels, while pregnant women and children are barred from the exercise.
Once vetted, the doctor-in charge sat them down to discuss the road ahead, as well as hand over the eight-page Informed Consent Document that explained in detail the vaccine, possible side-effects, the number of hospital visits required and the reimbursements for them, etc. They were also told that participants will be monitored for the next six months (187 days) for side-effects. “There was an initial apprehension of sorts, but once I understood the procedure in detail, I wasn’t too scared,” says Hema.
Continue reading your story on the app
Continue reading your story in the magazine
‘The Middle Class Buys Dreams. The Businessman Sells Unrealistic Ones'
Anand Kumar starts the interview by setting the context. “Let’s get the math right,” says the mathematician.
The Home School of Thought
Concerns over a monotonous, formal education system coupled with edtech’s innovative approaches bolster the homeschooling proposition. But is India ready for it?
The Big Small Question
As Byju’s and Unacademy grow at breakneck speed, what will it take for smaller edtech players to survive?
Beating Bharat's Edtech Blues
On the other side of the billion-dollar edtech boom are children who have been unable to access the most basic forms of online education, and people who have been trying to bridge the digital divide
Handa's New Funda: From Academy to Unacademy
How IITian Ravi Handa scaled up his seven-year-old online venture for MBA preparation, and eventually sold it to an edtech major
Six (and more) Degrees of Fakery
How inaction against the rash of fake universities across the country may be incentivising the mushrooming of more such institutions
Meet The Headmasters
Sequoia Capital has bet big on edtech, with over a dozen investments, including in industry giants Byju’s and Unacademy
A Billion-Dollar Dream For Freshworks
Girish Mathrubootham is taking a cue from the rapid growth of Silicon Valley software startups to reach scale and velocity
Changing How Small-Town India Shops
CityMall founders Angad Kikla and Naisheel Verdhan are building a network of micro-entrepreneurs through their app in smaller cities
Liberal Arts: A Road Less Travelled
Colleges offering these courses in India have begun to gain ground, but for them to truly shine on the global map, they must be cognisant of the country’s culture and challenges